Literature DB >> 20356941

Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis.

I T Zajac1, A H Whibley, S R Cole, D Byrne, J Guy, J Morcom, G P Young.   

Abstract

OBJECTIVES: To investigate the effect of general practice (GP) and general practitioner (GPR) endorsement for faecal occult blood test (FOBT)-based screening on maintenance of participation in screening over four successive screening rounds.
SETTING: South Australian residents aged > or = 50 years.
METHODS: Random selection of four groups (n = 600 per group): one from the Commonwealth electoral roll (ER) and three from the combined patient lists of two collaborating GPs (GP1, GP2, GP3). Subjects were mailed offers to screen using a faecal immunochemical test over four successive rounds, spaced approximately 18 months apart. The GP1 and ER groups were invited to screen without any endorsement from a GPR or medical practice; GP2 invitees received an invitation indicating support for screening from their medical practice; and GP3 invitations were printed on practice letterhead and were signed by a GPR.
RESULTS: Multivariate analyses indicated that initial participation as well as re-participation over four successive rounds was significantly enhanced in the GP2 (39%, 42%, 45% and 44%) and GP3 groups (42%, 47%, 48% and 49%) relative to the ER group (33%, 37%, 40% and 36%). The analyses also indicated that 60-69 year olds were most likely to participate in all rounds (relative risk [RR] 1.49, 1.39, 1.43 and 1.25), and men were generally less likely to participate than women in all screening rounds (RR 0.86, 0.84, 0.80 and 0.83).
CONCLUSIONS: Associating a GPR or medical practice of recent contact with an invitation to screen achieves better participation and re-participation than does an invitation from a centralized screening unit. Furthermore, enhanced participation can be achieved by practice endorsement alone without requiring actual GPR involvement.

Entities:  

Mesh:

Year:  2010        PMID: 20356941     DOI: 10.1258/jms.2010.009101

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  28 in total

1.  Self-reported bowel screening rates in older Australians and the implications for public health screening programs.

Authors:  Ian T Zajac; Ingrid Flight; Deborah Turnbull; Graeme Young; Steve Cole; Carlene Wilson
Journal:  Australas Med J       Date:  2013-08-31

2.  Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.

Authors:  Jason A Dominitz; Douglas J Robertson; Dennis J Ahnen; James E Allison; Margaret Antonelli; Kathy D Boardman; Maria Ciarleglio; Barbara J Del Curto; Grant D Huang; Thomas F Imperiale; Meaghan F Larson; David Lieberman; Theresa O'Connor; Timothy J O'Leary; Peter Peduzzi; Dawn Provenzale; Aasma Shaukat; Shahnaz Sultan; Amy Voorhees; Robert Wallace; Peter D Guarino
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

3.  Barriers to Colorectal Cancer Screening in a Primary Care Setting in Turkey.

Authors:  Mustafa Kursat Sahin; Servet Aker; Hatice Nilden Arslan
Journal:  J Community Health       Date:  2017-02

Review 4.  The role of primary care in early detection and follow-up of cancer.

Authors:  Jon D Emery; Katie Shaw; Briony Williams; Danielle Mazza; Julia Fallon-Ferguson; Megan Varlow; Lyndal J Trevena
Journal:  Nat Rev Clin Oncol       Date:  2013-11-19       Impact factor: 66.675

5.  Capsule colonoscopy increases uptake of colorectal cancer screening.

Authors:  Stefan Groth; Horst Krause; Rainer Behrendt; Helge Hill; Michael Börner; Murat Bastürk; Nora Plathner; Friedrich Schütte; Ulrich Gauger; Jürgen Ferdinand Riemann; Lutz Altenhofen; Thomas Rösch
Journal:  BMC Gastroenterol       Date:  2012-06-26       Impact factor: 3.067

6.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.

Authors:  Richard F A Logan; Julietta Patnick; Claire Nickerson; Lynn Coleman; Matt D Rutter; Christian von Wagner
Journal:  Gut       Date:  2011-12-07       Impact factor: 23.059

7.  Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.

Authors:  P Hewitson; A M Ward; C Heneghan; S P Halloran; D Mant
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

8.  Obesity and Cancer Screening according to Race and Gender.

Authors:  Heather Bittner Fagan; Richard Wender; Ronald E Myers; Nicholas Petrelli
Journal:  J Obes       Date:  2011-12-15

9.  Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.

Authors:  Sarah W Huf; David A Asch; Kevin G Volpp; Catherine Reitz; Shivan J Mehta
Journal:  J Gen Intern Med       Date:  2021-01-28       Impact factor: 6.473

10.  Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: a community-level perspective across varying levels of risk.

Authors:  Ryan J Courtney; Christine L Paul; Robert W Sanson-Fisher; Finlay A Macrae; Mariko L Carey; John Attia; Mark McEvoy
Journal:  BMC Public Health       Date:  2013-03-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.